Docsity
Docsity
Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity

Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan

Guidelines and tips
Guidelines and tips
Sell on Docsity
Sell on Docsity
Docsity AI
Docsity AI
Log inSign up

Prepare for your exams

Study with the several resources on Docsity

Find documents

Prepare for your exams with the study notes shared by other students like you on Docsity

Search for your university

Find the specific documents for your university's exams

Docsity AINEW

Summarize your documents, ask them questions, convert them into quizzes and concept maps

Explore questions

Clear up your doubts by reading the answers to questions asked by your fellow students

Earn points to download

Earn points by helping other students or get them with a premium plan

Share documents
download point icon20 Points

For each uploaded document

Answer questions
download point icon5 Points

For each given answer (max 1 per day)

All the ways to get free points
Get points immediately

Choose a premium plan with all the points you need

Study Opportunities

Choose your next study program

Get in touch with the best universities in the world. Search through thousands of universities and official partners

Community

Ask the community

Ask the community for help and clear up your study doubts

Free resources

Our save-the-student-ebooks!

Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors

Overview of Medical Conditions: Diagnosis and Management, Study Guides, Projects, Research of Cardiology

Cambridge Technical InstituteCardiology

A concise overview of various medical conditions, diagnostic approaches, and management strategies. It covers a wide range of topics, including endocrine disorders, neurological conditions, infectious diseases, and oncological issues. Key symptoms, diagnostic tests, and treatment options for each condition, making it a valuable resource for medical students and healthcare professionals seeking a quick reference guide. It includes information on both acute and chronic management strategies, as well as screening recommendations and lifestyle modifications.

Typology: Study Guides, Projects, Research

2025/2026

Available from 12/08/2025

mariebless0
mariebless0 🇺🇸

3.9

(7)

3.2K documents

1 / 76

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
CEA Exam Study Guide Revised Solutions
Part 1: Cardiovascular and Respiratory
Systems Cardiovascular System
1. Hypertension in African American Patients
● Preferred Medication: Calcium channel blockers (e.g., amlodipine) are
recommended as first-line therapy, particularly dihydropyridines if lifestyle
changes (e.g., DASH diet, salt restriction) fail to control blood pressure.
● Rationale: JNC8 guidelines recommend CCBs over ACE inhibitors in African
American patients due to better outcomes.
2. Uncontrolled Hypertension Complications
● Direct Complications: Chronic hypertension can cause proteinuria,
arteriovenous (AV) nicking, and hemorrhagic stroke.
● Peripheral Neuropathy: Associated more with diabetes but may co-occur in
hypertensive patients with diabetes.
3. Diastolic Dysfunction
● Definition: The heart's inability to relax fully, leading to reduced filling during
diastole.
● Significance: Common in patients with thickened myocardium; presents as
heart failure with preserved ejection fraction (HFpEF).
4. Congestive Heart Failure (CHF)
● Symptoms: Dyspnea on exertion, orthopnea, jugular venous distention
(JVD), and bilateral crackles.
● Diagnosis: JVD and pulmonary crackles indicate CHF over other
conditions like myocardial infarction (MI).
5. Heart Failure with Reduced Ejection Fraction (HFrEF) and Post-MI Care
● Management: Patients with EF <35% should use a LifeVest or
implantable cardioverter-defibrillator (AICD) for sudden cardiac
death prevention.
● Rationale: Low EF increases arrhythmia risk. Re-assessment with an
echocardiogram 2-3 months post-MI monitors recovery.
6. Aortic and Coronary Artery Disease
● Aortic Aneurysm Surveillance: CT angiography is preferred, offering precise
aneurysm measurements and detailed imaging for assessment.
● Coronary Artery Disease: High-risk patients (e.g., smokers, high LDL)
should be prescribed statins to reduce ASCVD risk.
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43
pf44
pf45
pf46
pf47
pf48
pf49
pf4a
pf4b
pf4c

Partial preview of the text

Download Overview of Medical Conditions: Diagnosis and Management and more Study Guides, Projects, Research Cardiology in PDF only on Docsity!

CEA Exam Study Guide Revised Solutions

Part 1: Cardiovascular and Respiratory Systems Cardiovascular System

  1. Hypertension in African American Patients ● Preferred Medication: Calcium channel blockers (e.g., amlodipine) are recommended as first-line therapy, particularly dihydropyridines if lifestyle changes (e.g., DASH diet, salt restriction) fail to control blood pressure. ● Rationale: JNC8 guidelines recommend CCBs over ACE inhibitors in African American patients due to better outcomes.
  2. Uncontrolled Hypertension Complications ● Direct Complications: Chronic hypertension can cause proteinuria, arteriovenous (AV) nicking, and hemorrhagic stroke. ● Peripheral Neuropathy: Associated more with diabetes but may co-occur in hypertensive patients with diabetes.
  3. Diastolic Dysfunction ● Definition: The heart's inability to relax fully, leading to reduced filling during diastole. ● Significance: Common in patients with thickened myocardium; presents as heart failure with preserved ejection fraction (HFpEF).
  4. Congestive Heart Failure (CHF) ● Symptoms: Dyspnea on exertion, orthopnea, jugular venous distention (JVD), and bilateral crackles. ● Diagnosis: JVD and pulmonary crackles indicate CHF over other conditions like myocardial infarction (MI).
  5. Heart Failure with Reduced Ejection Fraction (HFrEF) and Post-MI Care ● Management: Patients with EF <35% should use a LifeVest or implantable cardioverter-defibrillator (AICD) for sudden cardiac death prevention. ● Rationale: Low EF increases arrhythmia risk. Re-assessment with an echocardiogram 2-3 months post-MI monitors recovery.
  6. Aortic and Coronary Artery Disease ● Aortic Aneurysm Surveillance: CT angiography is preferred, offering precise aneurysm measurements and detailed imaging for assessment. ● Coronary Artery Disease: High-risk patients (e.g., smokers, high LDL) should be prescribed statins to reduce ASCVD risk.
  1. Orthostatic Hypotension and Severe Blood Loss

● Understand Pathophysiology: Grasp mechanisms of each condition, such as how chronic hypertension affects organs or the role of cardiac dysfunction in CHF symptoms. ● Memorize Key Medications and Rationales: Know first-line treatments and rationales, like calcium channel blockers for hypertension in African Americans or SABAs for mild COPD. ● Differentiate Symptoms: Recognize similar presentations, like CHF vs. MI, to avoid misdiagnosis. ● Imaging Choices: Recognize the best modality for each scenario (e.g., CT angiography for aneurysms, low-dose CT for lung cancer screening). ● PE Red Flags: Memorize classic PE symptoms and risk factors to facilitate timely diagnosis. Part 2: Gastrointestinal (GI) System Diverticulitis and Diverticulosis

  1. Diverticulosis ○ Definition: Presence of diverticula (small pouches) in the colon, often asymptomatic but can lead to bleeding or infection. ○ Risk Factors: Age > 40, low-fiber diet, obesity, and sedentary lifestyle. ○ Management: High-fiber diet to prevent progression to diverticulitis.
  2. Diverticulitis ○ Presentation: Often presents with left lower quadrant (LLQ) pain, fever, and leukocytosis. ○ Diagnosis: CT scan of the abdomen is the gold standard for diagnosing diverticulitis, identifying inflammation, and potential complications like abscess. ○ Treatment: Outpatient management includes antibiotics (e.g., ciprofloxacin and metronidazole) for mild cases. Severe cases may require hospitalization. Gastrointestinal Bleeding (GI Bleed)
  3. Upper GI Bleed ○ Common Causes: Peptic ulcer disease (PUD), gastritis, esophageal varices, Mallory-Weiss tears.

○ Symptoms: Hematemesis (vomiting blood) and melena (black, tarry stools).

○ Diagnosis: Elevated lipase (more specific than amylase); abdominal ultrasound or CT to identify causes like gallstones. ○ Management: NPO, IV fluids, pain control. Antibiotics are generally reserved for infections or complications.

  1. Chronic Pancreatitis ○ Etiology: Long-term alcohol use leading to irreversible pancreatic damage. ○ Symptoms: Chronic abdominal pain, malabsorption, and diabetes due to loss of pancreatic function. ○ Management: Pain management, pancreatic enzyme replacement, and abstinence from alcohol. Hepatitis
  2. Types ○ Hepatitis A: Fecal-oral transmission, typically self-limiting. Vaccination available. ○ Hepatitis B: Transmitted through blood and body fluids. Can become chronic; vaccination available. ○ Hepatitis C: Bloodborne, often through IV drug use. No vaccine but curable with antiviral therapy (e.g., direct-acting antivirals).
  3. Management of Chronic Hepatitis ○ Hepatitis B: Antiviral therapy may be used in chronic cases to prevent liver damage. ○ Hepatitis C: Treated with direct-acting antivirals, which can cure the infection.
  4. Liver Function Tests (LFTs) ○ Elevated ALT and AST suggest liver inflammation, while high bilirubin and alkaline phosphatase levels indicate cholestasis or bile duct obstruction. Gastroesophageal Reflux Disease (GERD)
  5. Symptoms and Differential Diagnosis ○ Typical Symptoms: Heartburn, regurgitation, chronic cough, sore throat. Symptoms worsen post-meal or when lying down. ○ Differentiation: Important to rule out cardiac causes in older adults with risk factors.
  6. Diagnosis

○ Clinical Diagnosis: Based on symptoms; upper endoscopy if alarm symptoms (e.g., weight loss, dysphagia) or if treatment fails.

  1. Management ○ Lifestyle Changes: Weight loss, avoidance of trigger foods, bed elevation. ○ Medications: PPIs are first-line for moderate to severe symptoms, with H2 blockers as an option for mild symptoms. Irritable Bowel Syndrome (IBS)
  2. Types ○ IBS-D: Diarrhea-predominant. ○ IBS-C: Constipation-predominant. ○ IBS-M: Mixed diarrhea and constipation.
  3. Management ○ Dietary Changes: Low FODMAP diet helps reduce bloating and discomfort. ○ Medications: Antispasmodics (e.g., dicyclomine), loperamide for diarrhea, fiber supplements for constipation.
  4. Diagnostic Criteria ○ Rome IV Criteria: Recurrent abdominal pain at least 1 day per week in the last 3 months, with two or more of the following: related to defecation, stool frequency change, or stool form change. Inflammatory Bowel Disease (IBD)
  5. Crohn’s Disease vs. Ulcerative Colitis ○ Crohn’s Disease: Can affect any GI tract part, often with skip lesions. Symptoms include diarrhea, pain, weight loss, perianal disease. ○ Ulcerative Colitis (UC): Limited to colon and rectum with continuous inflammation. Symptoms include bloody diarrhea, urgency, and tenesmus.
  6. Diagnosis ○ Colonoscopy with Biopsy: Essential for differentiating Crohn’s (granulomas) from UC (crypt abscesses). ○ Imaging: CT or MRI enterography for Crohn’s small bowel involvement.
  7. Management ○ Medications: Aminosalicylates (e.g., mesalamine), corticosteroids for flares, immunomodulators, and biologics for severe cases.

○ Etiology: Insulin resistance and relative insulin deficiency, often associated with obesity, metabolic syndrome, and family history. ○ Management: Lifestyle changes are first-line; oral medications (e.g., metformin) are typically the first pharmacologic treatment. In advanced cases, insulin may be necessary. ○ Complications: Neuropathy, nephropathy, retinopathy, and increased cardiovascular risk. Routine screening includes annual eye exams, foot exams, and kidney function tests (urine microalbumin).

  1. Diabetes Screening and Diagnosis ○ Criteria: Fasting glucose ≥ 126 mg/dL, HbA1c ≥ 6.5%, or 2-hour plasma glucose ≥ 200 mg/dL on an OGTT. ○ Screening: Recommended for adults over 45 or earlier in individuals with risk factors (e.g., obesity, family history).
  2. Hypoglycemia Management ○ Symptoms: Shakiness, sweating, confusion, dizziness, palpitations. ○ Management: Rule of 15 (15g of glucose, recheck blood sugar in 15 minutes). Glucagon injections for severe hypoglycemia in unconscious patients. Thyroid Disorders
  3. Hypothyroidism ○ Etiology: Most common cause is Hashimoto's thyroiditis, an autoimmune condition. ○ Symptoms: Fatigue, weight gain, cold intolerance, constipation, dry skin, and bradycardia. ○ Diagnosis: Elevated TSH and low free T4. ○ Management: Levothyroxine is the treatment of choice, starting with a low dose (e.g., 25 mcg) in older adults to prevent overtreatment side effects like arrhythmias.
  4. Hyperthyroidism ○ Etiology: Commonly caused by Graves' disease (autoimmune). Other causes include toxic multinodular goiter and thyroiditis. ○ Symptoms: Weight loss, heat intolerance, tremors, palpitations, and increased appetite.

○ Diagnosis: Low TSH with high T3/T4 levels; additional tests include radioactive iodine uptake (RAIU) for Graves’ disease. ○ Management: Beta-blockers for symptom control, antithyroid medications (e.g., methimazole), or radioactive iodine therapy.

  1. Thyroid Nodules and Cancer Screening ○ Evaluation: TSH levels and ultrasound imaging. Fine-needle aspiration (FNA) biopsy is recommended for nodules with suspicious features on ultrasound. ○ Red Flags: Rapidly growing nodule, hoarseness, or lymphadenopathy may indicate malignancy. Adrenal Disorders
  2. Cushing's Syndrome ○ Etiology: Excess cortisol, often due to long-term steroid use, adrenal tumors, or ACTH-producing pituitary adenomas. ○ Symptoms: Moon face, buffalo hump, central obesity, purple striae, hypertension, and hyperglycemia. ○ Diagnosis: 24-hour urinary cortisol, low-dose dexamethasone suppression test, or late-night salivary cortisol test. ○ Management: Gradual tapering of steroids if iatrogenic, surgical removal of tumors, or medications to block cortisol synthesis.
  3. Addison’s Disease (Primary Adrenal Insufficiency) ○ Etiology: Autoimmune destruction of adrenal cortex, leading to cortisol and aldosterone deficiency. ○ Symptoms: Fatigue, hypotension, hyperpigmentation, salt craving, and electrolyte imbalances (hyponatremia, hyperkalemia). ○ Diagnosis: Low morning cortisol and elevated ACTH; ACTH stimulation test for confirmation. ○ Management: Corticosteroid replacement (e.g., hydrocortisone) and fludrocortisone for mineralocorticoid deficiency.
  4. Pheochromocytoma ○ Etiology: Rare catecholamine-secreting tumor of the adrenal medulla. ○ Symptoms: Episodes of severe hypertension, palpitations, headache, sweating, and anxiety. ○ Diagnosis: Elevated plasma metanephrines or 24-hour urinary catecholamines.

○ Symptoms: Polyuria, polydipsia, and dilute urine. ○ Diagnosis: Water deprivation test and desmopressin (DDAVP) response differentiates central from nephrogenic DI. ○ Management: Central DI is treated with desmopressin; nephrogenic DI may require thiazide diuretics. Key Review Points and Study Tips for Endocrine System ● Understand Hormone Pathways: Know which glands secrete which hormones (e.g., pituitary gland’s role in GH, TSH, ACTH) and how they impact downstream organs. ● Memorize Lab Markers for Endocrine Disorders: Familiarize yourself with diagnostic lab values, like TSH/T4 for thyroid disorders, cortisol/ACTH for adrenal issues, and calcium/PTH for parathyroid conditions. ● Identify Symptoms of Hormone Excess or Deficiency: Recognize how hormone levels (high or low) impact symptoms—such as hyperglycemia in Cushing's or muscle cramps in hypoparathyroidism. ● High-Yield Management Protocols: Memorize first-line treatments and management strategies (e.g., levothyroxine for hypothyroidism, metformin for type 2 diabetes). Part 12: Endocrine System Diabetes Mellitus

  1. Type 1 Diabetes Mellitus (T1DM) ○ Etiology: Autoimmune destruction of pancreatic beta cells, leading to insulin deficiency. ○ Presentation: Polyuria, polydipsia, polyphagia, weight loss, and ketoacidosis (diabetic ketoacidosis or DKA). ○ Diagnosis: ■ Fasting Glucose: ≥126 mg/dL. ■ HbA1c: ≥6.5%. ■ Random Glucose: ≥200 mg/dL with symptoms. ○ Management: Insulin therapy (basal-bolus regimen with long- acting and rapid-acting insulin).
  2. Type 2 Diabetes Mellitus (T2DM) ○ Etiology: Insulin resistance with relative insulin deficiency, commonly associated with obesity and metabolic syndrome. ○ Presentation: Often asymptomatic; may have polyuria, polydipsia, blurred vision.

○ Diagnosis: Same criteria as T1DM. ○ Management: ■ Lifestyle Modifications: Diet, exercise, weight management. ■ First-Line Medications: Metformin. ■ Additional Agents: GLP-1 agonists (e.g., liraglutide), SGLT inhibitors (e.g., empagliflozin) for cardiovascular benefits in high-risk patients.

  1. Complications: ○ Microvascular: Retinopathy, nephropathy, neuropathy. ○ Macrovascular: Increased risk of cardiovascular disease. ○ Prevention: Annual eye exams, foot care, BP control, statin therapy if indicated. Hypothyroidism
  2. Etiology: Most common cause is Hashimoto’s thyroiditis (autoimmune).
  3. Presentation: Fatigue, weight gain, cold intolerance, dry skin, constipation, bradycardia.
  4. Diagnosis: ○ TSH: Elevated. ○ Free T4: Low.
  5. Management: Levothyroxine, starting at a lower dose in elderly or cardiac patients. Monitor TSH every 6-8 weeks after starting or adjusting dose. Hyperthyroidism
  6. Etiology: Graves’ disease (most common), toxic multinodular goiter, thyroiditis.
  7. Presentation: Weight loss, heat intolerance, tremor, palpitations, exophthalmos (specific to Graves’ disease).
  8. Diagnosis: ○ TSH: Suppressed. ○ Free T4/T3: Elevated. ○ RAIU: Increased uptake in Graves’, decreased in thyroiditis.
  9. Management: ○ Beta-Blockers: Symptom control (e.g., propranolol). ○ Antithyroid Medications: Methimazole or propylthiouracil (PTU). ○ Radioactive Iodine: For definitive treatment in non-pregnant patients.
  1. Etiology: Primary hyperparathyroidism (adenoma) or secondary (CKD).
  2. Presentation: “Stones, bones, abdominal groans, and psychic moans” (kidney stones, bone pain, abdominal discomfort, mood changes).
  3. Diagnosis: ○ Calcium: Elevated. ○ PTH: Elevated in primary hyperparathyroidism. ○ Vitamin D: Often low in secondary hyperparathyroidism.
  4. Management: ○ Primary: Parathyroidectomy if symptomatic or high calcium. ○ Secondary: Manage underlying cause (e.g., vitamin D supplementation in CKD). Adrenal Disorders
  5. Cushing’s Syndrome ○ Etiology: Prolonged exposure to cortisol (exogenous steroids or adrenal tumor). ○ Presentation: Central obesity, moon face, buffalo hump, purple striae, hypertension, hyperglycemia. ○ Diagnosis: ■ 24-hour Urine Free Cortisol. ■ Low-Dose Dexamethasone Suppression Test. ○ Management: Gradual steroid taper if exogenous; surgical removal of adrenal tumor if endogenous.
  6. Addison’s Disease (Primary Adrenal Insufficiency) ○ Etiology: Autoimmune destruction of adrenal cortex, leading to cortisol and aldosterone deficiency. ○ Presentation: Fatigue, weight loss, hyperpigmentation, hypotension, hyponatremia, hyperkalemia. ○ Diagnosis: ■ Low Cortisol and High ACTH. ■ ACTH Stimulation Test. ○ Management: Corticosteroid (e.g., hydrocortisone) and mineralocorticoid (fludrocortisone) replacement.
  7. Pheochromocytoma ○ Etiology: Catecholamine-secreting tumor of the adrenal medulla. ○ Presentation: Severe hypertension, palpitations, sweating, headache.

○ Diagnosis: ■ Plasma Metanephrines or 24-hour Urine Catecholamines. ○ Management: Surgical resection after blood pressure control with alpha-blockers (e.g., phenoxybenzamine). Pituitary Disorders

  1. Acromegaly ○ Etiology: Excess growth hormone (GH) due to pituitary adenoma. ○ Presentation: Enlarged hands/feet, coarse facial features, joint pain. ○ Diagnosis: ■ Elevated IGF-1. ■ Oral Glucose Suppression Test: Lack of GH suppression confirms. ○ Management: Surgery (transsphenoidal resection), medications like octreotide.
  2. Diabetes Insipidus (DI) ○ Types: Central DI (lack of ADH production) and nephrogenic DI (kidneys unresponsive to ADH). ○ Presentation: Polyuria, polydipsia, dilute urine. ○ Diagnosis: ■ Water Deprivation Test: Confirms DI. ■ Desmopressin Test: Differentiates central from nephrogenic. ○ Management: Desmopressin (DDAVP) for central DI; thiazide diuretics for nephrogenic DI. Thyroid Nodules and Cancer
  3. Thyroid Nodules ○ Evaluation: TSH level, ultrasound imaging. Biopsy (fine-needle aspiration) if nodule >1 cm with suspicious features. ○ Benign Nodules: Often managed with regular monitoring.
  4. Thyroid Cancer ○ Types: ■ Papillary: Most common, slow-growing. ■ Follicular: Often invades blood vessels. ■ Medullary: Associated with MEN syndromes. ■ Anaplastic: Aggressive, poor prognosis.

○ Common Causes: Diabetes and hypertension are the leading causes of CKD, often resulting in progressive kidney damage over time. ○ Stages: CKD is staged from 1 to 5 based on the glomerular filtration rate (GFR): ■ Stage 1: GFR > 90 with kidney damage markers. ■ Stage 2: GFR 60-89. ■ Stage 3: GFR 30-59. ■ Stage 4: GFR 15-29. ■ Stage 5: GFR < 15 (end-stage renal disease, ESRD).

  1. Management ○ Blood Pressure Control: ACE inhibitors (e.g., lisinopril) or ARBs are recommended for hypertension management in CKD as they reduce proteinuria and slow progression. ○ Diabetes Management: Tight glycemic control (HbA1c < 7%) to prevent further kidney damage. ○ Avoid Nephrotoxic Drugs: NSAIDs and certain antibiotics (e.g., aminoglycosides) should be avoided to prevent further renal damage.
  2. Complications ○ Anemia: Due to decreased erythropoietin production; treat with erythropoiesis-stimulating agents (ESAs) and iron supplementation. ○ Electrolyte Imbalances: Hyperkalemia and hyperphosphatemia are common in advanced CKD, managed through dietary restrictions and medications (e.g., phosphate binders). Acute Kidney Injury (AKI)
  3. Classification ○ Prerenal AKI: Due to decreased blood flow to the kidneys, often from hypotension or dehydration. ○ Intrarenal (Intrinsic) AKI: Due to direct kidney damage, often caused by nephrotoxic drugs, infections, or contrast dye. ○ Postrenal AKI: Due to obstruction of urine flow, such as from kidney stones or prostate enlargement.
  4. Diagnosis

○ Laboratory Markers: Elevated blood urea nitrogen (BUN) and creatinine. Prerenal AKI often has a BUN ratio > 20:1. ○ Urinalysis: May show casts or abnormal cells depending on the type of AKI (e.g., muddy brown casts in acute tubular necrosis).

  1. Management ○ Prerenal AKI: Restore perfusion through fluid replacement and blood pressure support. ○ Intrarenal AKI: Avoid nephrotoxins, consider diuretics if volume overloaded. ○ Postrenal AKI: Relieve obstruction, possibly with catheterization or surgical intervention. Urinary Tract Infections (UTIs)
  2. Classification ○ Uncomplicated UTI: Often in healthy, non-pregnant women; typically due to Escherichia coli. ○ Complicated UTI: Associated with factors like catheter use, structural abnormalities, or diabetes. ○ Pyelonephritis: A UTI involving the kidneys, presenting with fever, flank pain, and possibly nausea/vomiting.
  3. Diagnosis ○ Urinalysis: Positive leukocyte esterase, nitrites (often indicate E. coli), and white blood cells (WBCs). ○ Urine Culture: Confirmatory for diagnosis, especially in complicated cases or treatment failure.
  4. Management ○ Uncomplicated UTI: First-line treatment with nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), or fosfomycin. ○ Complicated UTI/Pyelonephritis: Fluoroquinolones (e.g., ciprofloxacin) are often used for more severe infections or if outpatient therapy is not sufficient.
  5. Prevention ○ Lifestyle Modifications: Increase water intake, avoid irritants, urinate after intercourse, and consider cranberry supplements for UTI prevention.